OKOTOKS - Mullen Group Ltd. reported its third-quarter profit fell compared with a year ago as acquisitions helped boost its revenue.
8m
JASCAYD® (nerandomilast) approved in China for the treatment of idiopathic pulmonary fibrosis (IPF)
Nerandomilast is an oral, preferential inhibitor of PDE4B approved for the treatment of IPF in adult patients. Nerandomilast was approved by the U.S. Food and Drug Administration (FDA) after securing ...
DataVault AI, Inc. (“DataVault”) (NASDAQ: DVLT), leading the way in AI data experience, valuation, and monetization, and Wellgistics Health, ...
OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Aviva PLC (LSE: ...
VANCOUVER - Teck Resources Ltd. reported a profit in its latest quarter compared with a loss a year ago as its revenue rose.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback